Sugiura H - Search Results

1

Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer.

Sugiura H, Toyama T, Hara Y, Zhang Z, Kobayashi S, Fujii Y, Iwase H, Yamashita H. Sugiura H, et al. Jpn J Clin Oncol. 2007 Nov;37(11):820-8. doi: 10.1093/jjco/hym114. Epub 2007 Oct 11. Jpn J Clin Oncol. 2007. PMID: 17932113

2

Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.

Toyama T, Iwase H, Yamashita H, Hara Y, Omoto Y, Sugiura H, Zhang Z, Fujii Y. Toyama T, et al. Among authors: sugiura h. Cancer Lett. 2003 Jan 10;189(1):97-102. doi: 10.1016/s0304-3835(02)00463-9. Cancer Lett. 2003. PMID: 12445683

3

Estrogen receptor alpha mutation (A-to-G transition at nucleotide 908) is not found in different types of breast lesions from Japanese women.

Zhang Z, Yamashita H, Toyama T, Omoto Y, Sugiura H, Hara Y, Haruki N, Kobayashi S, Iwase H. Zhang Z, et al. Among authors: sugiura h. Breast Cancer. 2003;10(1):70-3. doi: 10.1007/BF02967628. Breast Cancer. 2003. PMID: 12525766

4

Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.

Iwase H, Zhang Z, Omoto Y, Sugiura H, Yamashita H, Toyama T, Iwata H, Kobayashi S. Iwase H, et al. Among authors: sugiura h. Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S34-8. doi: 10.1007/s00280-003-0592-1. Epub 2003 Jun 19. Cancer Chemother Pharmacol. 2003. PMID: 12819932

5

Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.

Zhang Z, Yamashita H, Toyama T, Omoto Y, Sugiura H, Hara Y, Wu X, Kobayashi S, Iwase H. Zhang Z, et al. Among authors: sugiura h. Breast Cancer Res. 2003;5(6):R250-6. doi: 10.1186/bcr657. Epub 2003 Oct 9. Breast Cancer Res. 2003. PMID: 14580261 Free PMC article.

6

Biweekly paclitaxel in patients with metastatic breast cancer.

Toyama T, Yamashita H, Hara Y, Sugiura H, Fujii Y, Iwase H. Toyama T, et al. Among authors: sugiura h. Int J Clin Oncol. 2003 Dec;8(6):357-61. doi: 10.1007/s10147-003-0353-5. Int J Clin Oncol. 2003. PMID: 14663637 Clinical Trial.

7

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer.

Yamashita H, Nishio M, Toyama T, Sugiura H, Zhang Z, Kobayashi S, Iwase H. Yamashita H, et al. Among authors: sugiura h. Breast Cancer Res. 2004;6(1):R24-30. doi: 10.1186/bcr738. Epub 2003 Nov 7. Breast Cancer Res. 2004. PMID: 14680497 Free PMC article.

8

HDAC6 expression is correlated with better survival in breast cancer.

Zhang Z, Yamashita H, Toyama T, Sugiura H, Omoto Y, Ando Y, Mita K, Hamaguchi M, Hayashi S, Iwase H. Zhang Z, et al. Among authors: sugiura h. Clin Cancer Res. 2004 Oct 15;10(20):6962-8. doi: 10.1158/1078-0432.CCR-04-0455. Clin Cancer Res. 2004. PMID: 15501975

9

ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.

Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Kawaguchi M, Miura Y, Iwase H. Zhang Z, et al. Among authors: sugiura h. Clin Cancer Res. 2005 Jan 1;11(1):193-8. Clin Cancer Res. 2005. PMID: 15671546

10

NCOR1 mRNA is an independent prognostic factor for breast cancer.

Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Hara Y, Kobayashi S, Iwase H. Zhang Z, et al. Among authors: sugiura h. Cancer Lett. 2006 Jun 8;237(1):123-9. doi: 10.1016/j.canlet.2005.05.046. Epub 2005 Jul 12. Cancer Lett. 2006. PMID: 16019133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

967 results

Search Page

Filters